Paula Deen's Diabetes Drug Deal in Jeopardy

Paula Deen’s Diabetes Drug Deal in Jeopardy

Image: File

paula deen smilingWith all the talk about the her racist remarks, people probably forgot that Paula Deen revealed she has Type 2 diabetes last year. Deen’s revelations led to a lucrative endorsement deal with a diabetes drug company.

Now, the Danish pharmaceutical company, Novo Nordisk, has suspended its relationship with Deen following her n-word controversy. Deen was paid $6 million for a two-year contract to promote the drug Victoza, the New York Times reports.

From the company’s statement issued on Thursday: “Novo Nordisk and Paula Deen have mutually agreed to suspend our patient education activities for now, while she takes time to focus her attention where it is needed.”

Suspension of Deen’s lucrative deal follows announcements by Target, Home Depot and Wal-Mart that they would stop carrying her products. QVC may be on the verge of doing the same.